NPPB and endothelial dysfunction: In conclusion, MAD therapy addresses multiple cardiovascular mechanisms—oxidative stress, inflammation, endothelial dysfunction, NT-proBNP concentrations, LV function, HRV, and the prevention of cardiovascular events—making it an essential treatment option for reducing the cardiovascular risk associated with OSA.